Skip to content
Open access · CC-BY via OpenAlex

Characterization of Mitochondrial Bioenergetics in Preeclampsia

Venkata Ramana Vaka, Evangeline M. Deer, Mark Cunningham, Kristen McMaster, Kedra L. Wallace, Denise C. Cornelius, Lorena Machado Amaral, Babbette B LaMarca

Journal of Clinical Medicine · 2021 · ▲ 24 citations

Abstract

Preeclampsia (PE) is characterized by new onset hypertension during pregnancy and is associated with oxidative stress, placental ischemia, and autoantibodies to the angiotensin II type I receptor (AT1-AA). Mitochondrial (mt) dysfunction in PE and various sources of oxidative stress, such as monocytes, neutrophils, and CD4 + T cells, have been identified as important players in the pathophysiology of PE. We have established the significance of AT1-AA, TNF-α, and CD4 + T cells in causing mitochondrial (mt) dysfunction in renal and placental tissues in pregnant rats. Although the role of mt dysfunction from freshly isolated intact placental mitochondria has been compared in human PE and normally pregnant (NP) controls, variations among preterm PE or term PE have not been compared and mechanisms contributing to mt ROS during PE are unclear. Therefore, we hypothesized PE placentas would exhibit impaired placental mt function, which would be worse in preterm PE patients than in those of later gestational ages. Immediately after delivery, PE and NP patient's placentas were collected, mt were isolated and mt respiration and ROS were measured. PE patients at either < or >34 weeks gestational age (GA) exhibited elevated blood pressure and decreased placental mt respiration rates (state 3 and maximal). Patients delivering at >34 weeks exhibited decreased Complex IV activity and expression. Placental mtROS was significantly reduced in both PE groups, compared to NP placental mitochondria. Collectively, the study demonstrates that PE mt dysfunction occurs in the placenta, with mtROS being lower than that seen in NP controls. These data indicate why antioxidants, as a potential target or new therapeutic agent, may not be ideal in treating the oxidative stress associated with PE.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/jcm10215063
Canonical
link ↗
Fetched
2026-10-28 MST

Cite this

APA
Vaka, V.R., Deer, E.M., Cunningham, M., McMaster, K., Wallace, K.L., Cornelius, D.C., Amaral, L.M., &amp; LaMarca, B.B. (2021). Characterization of Mitochondrial Bioenergetics in Preeclampsia. <em>Journal of Clinical Medicine</em>. https://doi.org/10.3390/jcm10215063
Vancouver
Vaka VR, Deer EM, Cunningham M, McMaster K, Wallace KL, Cornelius DC, et al. Characterization of Mitochondrial Bioenergetics in Preeclampsia. Journal of Clinical Medicine. 2021. doi:10.3390/jcm10215063.
BibTeX
@article{venkata2021Charac, title = {Characterization of Mitochondrial Bioenergetics in Preeclampsia}, author = {Venkata Ramana Vaka and Evangeline M. Deer and Mark Cunningham and Kristen McMaster and Kedra L. Wallace and Denise C. Cornelius and Lorena Machado Amaral and Babbette B LaMarca}, journal = {Journal of Clinical Medicine}, year = {2021}, doi = {10.3390/jcm10215063}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings